Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Emerging molecular mechanism of neuroinflammation in Parkinson's disease: A JAK/STAT and TGFβ/SMAD signaling crosstalk

Purkayastha K, Roy A, Bhattacharya P, Borah A.

Biochim Biophys Acta Gen Subj. 2026 Aug 18;1870(11):130989. doi: 10.1016/j.bbagen.2026.130989. Online ahead of print.

Regenerative medicine for neurodegenerative diseases:History, Strategies, and Clinical Advances

Li J, Duan H, Hao P, Zhao W, Gao Y, Yang Z, Li X.

Transl Res. 2026 Aug 18:S1931-5244(26)00171-4. doi: 10.1016/j.trsl.2026.08.005. Online ahead of print.

Advances in the clinical application of mesenchymal stem cells for neurological disorders

Jamali MC, Shafie A, Alqahtani AJ, Al-Samawi RI, Alyami HM, Ashour AA, Felemban MF, Mansuri N, Tayeb FJ, Ahmad I, Mudhafar M, Sheweita SA.

Stem Cell Res Ther. 2026 Aug 18;17(1):285. doi: 10.1186/s13287-026-05229-5.

PCSK9 inhibitors in neurodegenerative disorders: mechanisms, therapeutic potential, and clinical implications

Wang JDJ, Teo AYT, Xiao B, Chao Y, Zhou ZD, Tan BJ, Chan LL, Rosalie E, Tan EK.

Transl Neurodegener. 2026 Aug 18;15(1):39. doi: 10.1186/s40035-026-00568-y.

Dopaminergic neuronal dysfunction induced by newer generation systemic insecticides in Caenorhabditis elegans

Filipowicz AR, Bui K, Osman N, Morton KS, Kenny-Ganzert IW, Sherwood DR, Meyer JN, Allard P.

bioRxiv [Preprint]. 2026 Jun 18:2026.06.14.732178. doi: 10.64898/2026.06.14.732178.

Parkinson's Disease: Immunometabolic Control Points Across Neural, Vascular, and Peripheral Systems

Narvaez Irizarry Felix Y, Bermudez Adorno Alondra M, Boris E, Lilia K, Mikhail I.

Parkinsons Dis. 2026 Aug 17;2026:5349481. doi: 10.1155/padi/5349481. eCollection 2026.

Understanding neurodegeneration and regeneration in the CNS: New concepts, clinical investigations, and an unsung hero of neuroscience

Walczak P, Li S, Ji X, Boltze J.

Neuroprotection. 2026 Aug 18:10.1002/nep3.70058. doi: 10.1002/nep3.70058. Online ahead of print.

Immunometabolic reprogramming of central and peripheral immune cells in mental disorders: mechanisms and therapeutic implications

Lin K, Wang P, Li S, Ma C, Wen D, Wang X, Liao L.

Front Immunol. 2026 Aug 4;17:1712425. doi: 10.3389/fimmu.2026.1712425. eCollection 2026.

Rehabilitation strategies for atypical parkinsonian syndromes: A scoping review of progressive supranuclear palsy, multiple system atrophy, corticobasal syndrome, and dementia with Lewy bodies

Kamo H, Amano S, Gerzenshtein IK, Vuddandam DK, Nagaki K, Shimizu M, Tran MV, Elavarasi A, McFarland NR, Shukla AW.

J Parkinsons Dis. 2026 Aug 19:1877718X261440430. doi: 10.1177/1877718X261440430. Online ahead of print.

Meta-analysis and pharmacoeconomic study of rasagiline versus selegiline in the treatment of Parkinson's disease

Zhou H, Li D, Yu J, Gu Z, Wei H.

Ann Med. 2026 Dec;58(1):2711475. doi: 10.1080/07853890.2026.2711475. Epub 2026 Aug 19.

Towards the Prevention of Freezing of Gait in Parkinson's Disease

Tosserams A, Nonnekes J, Bloem BR, Postma EM.

Eur J Neurosci. 2026 Aug;64(4):e70636. doi: 10.1111/ejn.70636.

Redefining Parkinson's disease: microglia and systemic immunity as gateways to early therapy

Michelucci A, Tziortziou M, Grünewald A.

Neurodegener Dis Manag. 2026 Aug 20:1-4. doi: 10.1080/17582024.2026.2721683. Online ahead of print.

Ringer Loss in Drosophila Uncovers Mitochondrial Complex I Deficits Relevant to Human Parkinson's Disease

Tillmon HG, Boyen SK, Velazquez R, Urbina-Berlanga ME, Sciortino M, Banerjee S.

bioRxiv [Preprint]. 2026 Oct 8:2026.07.27.741040. doi: 10.64898/2026.07.27.741040.

Time Course and Microcircuit Mechanisms of Primary Motor Cortex Dysfunction in Progressive Parkinsonism

Chen L, Chehade HD, Somavarapu S, Chu HY.

bioRxiv [Preprint]. 2026 Jul 30:2026.07.27.741031. doi: 10.64898/2026.07.27.741031.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias